Moderna, Inc. (FRA:0QF)

Market Cap	8.57B
Revenue (ttm)	2.62B
Net Income (ttm)	-2.47B
Shares Out	n/a
EPS (ttm)	-6.41
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	254
Average Volume	39,657
Open	21.61
Previous Close	21.04
Day's Range	21.61 - 21.61
52-Week Range	19.89 - 61.17
Beta	n/a
RSI	45.36
Earnings Date	Nov 6, 2025

About Moderna

Moderna, Inc., a biotechnology company, provides messenger RNA medicines in the United States, Europe, and internationally. The company’s respiratory vaccines include spikevax, mRESVIA, COVID, RSV, seasonal influenza, combination, and pandemic influenza vaccine; latent vaccines comprise cytomegalovirus, epstein-barr virus, herpes simplex virus, varicella zoster virus, and human immunodeficiency virus vaccines; enteric viruses include norovirus; public health vaccines consist of Zika, Nipah, and Mpox vaccines; and bacterial diseases vaccines, su...

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 2010
• Employees: 5,800
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: 0QF

Financial Performance

In 2024, Moderna's revenue was $3.24 billion, a decrease of -52.75% compared to the previous year's $6.85 billion. Losses were -$3.56 billion, -24.46% less than in 2023.

Financial numbers in USD